Birtamimab
泊特埃单抗
Report date: 2025/07/09 20:00:48
Base Information
Drug NameBirtamimab
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[22]
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNeotope BiosciencesOnclave Therapeutics
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesProthena Biosciences LtdTufts Medical Center Inc
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A